Eversense 365 is the world’s first and only one year CGM, which was approved by the United States (US) Food and Drug Administration in September of 2024 and launched across the country in October of ...
Zacks Investment Research on MSN
SENS stock up as Eversense 365 CGM wins European CE mark approval
Senseonics Holdings, Inc. SENS recently scored a meaningful regulatory win in Europe, receiving CE Mark approval for its ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results